September 18, 2018 | Letisia Marquez
Saul Priceman, Ph.D., an assistant research professor with City of Hope’s T Cell Immunotherapy Laboratory, is focused on developing more CAR T clinical trials for patients battling solid tumor cancers like breast and prostate cancer.
City of Hope scientist's stem cell model could be key to slowing Alzheimer's
September 28, 2018 | Zen Vuong
Treatments for a rare nervous system disorder and, eventually, Alzheimer's disease could be influenced by new research conducted by City of Hope's Yanhong Shi, Ph.D.
New Genome-Editing Platform Poised To Fuel The Next Generation Of Genetic Medicines
July 17, 2018 | Zen Vuong
A novel gene-editing tool discovered at City of Hope has the potential to treat a variety of genetic diseases.
Core Connection: Light Microscopy and Digital Imaging
May 23, 2018 | Katie Neith
Microscopes have been the backbone of many scientific experiments since at least the 1600s, but as technology rapidly progresses, these instruments become more complex and harder to use. Nonetheless, microscopes, paired with advanced digital imaging techniques, remain critical tools for biomedical research, disease diagnostics and in tracking the body’s response to treatment therapies. They are also necessary for producing quality images for journal submissions and grant proposals.
Test Finds Promising New Drug to Treat Chronic Myelogenous Leukemia
May 15, 2018 | Katie Neith
City of Hope researchers may have discovered a more effective treatment for patients with chronic myelogenous leukemia (CML) according to a study published today in Nature Medicine.
CIRM Grants Nearly $6M to Promising Sickle Cell Research
May 15, 2018 | Michael Easterling
City of Hope’s Joseph Rosenthal, M.D., and his team can advance their research into finding a cure for sickle cell disease, thanks to a $5.74 million award from the California Institute for Regenerative Medicine.
TGen Tests Ultrasound to Enhance Drug Delivery in Cancer Therapy
May 15, 2018 | City of Hope
TGen (a City of Hope affiliate) has teamed up with a Norwegian biotech company to test the use of ultrasounds to direct and focus cancer drug therapies.
Jianjun Chen, Ph.D., Takes Aim at Acute Myeloid Leukemia
May 15, 2018 | City of Hope
Jianjun Chen, Ph.D., a new faculty member at City of Hope, dedicates much of his research program to learning more about acute myeloid leukemia (AML), one of the most common and deadly forms of blood cancer.
City of Hope Researchers Find B Cell "Achilles' Heel"
May 14, 2018 | Katie Neith
City of Hope's Markus Müschen, M.D., Ph.D., and Gang Xiao, Ph.D., and their team of researchers reported in a recent paper published in the journal Cell, on the discovery of a new therapeutic target for B cell malignancies.